Status:
COMPLETED
SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Covid19
SARS-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion o...
Eligibility Criteria
Inclusion
- The patient population is defined as all adult patients hospitalized in the University Hospital Basel from April 1st, 2020 to June 14th, 2020.
Exclusion
- Outpatients
- Patients with SARS-CoV-2 screening in the outpatient test center
- Patients with a SARS-CoV-2 test more than 72 hours before hospital admission
- Test not performed (for any reason)
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
4099 Patients enrolled
Trial Details
Trial ID
NCT04519372
Start Date
April 1 2020
End Date
March 31 2021
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology
Basel, Switzerland, 4031